PIK3CA and gastric cancer: From the results of existing clinical investigations in GC, the efficacy of PI3K inhibitors, AKT inhibitors, mTOR inhibitors, and other monotherapy were not as effective as dual PI3K/mTOR inhibitors or several combination therapies,195 suggesting that the restriction on the therapeutic effect by the heterogeneity of GC should be emphasized in designing new targeted medication regimens.